Genetic screens reveal new targetable vulnerabilities in BAP1-deficient mesothelioma

February 22, 2023 | Comments Off on Genetic screens reveal new targetable vulnerabilities in BAP1-deficient mesothelioma

Cell Reports. Medicine 2023 January 10 [Link] Gaurav Kumar Pandey, Nick Landman, Hannah K Neikes, Danielle Hulsman, Cor Lieftink, Roderick Beijersbergen, Krishna Kalyan Kolluri, Sam M Janes, Michiel Vermeulen, Jitendra…

Serum diagnostic markers for malignant pleural mesothelioma: a narrative review

February 21, 2023 | Comments Off on Serum diagnostic markers for malignant pleural mesothelioma: a narrative review

Translational Cancer Research 2022 December [Link] Jing-Jing Wang, Li Yan Abstract Background and objective: The prognosis of patients with malignant pleural mesothelioma (MPM) is poor, and early diagnosis is key…

Unusually Aggressive Presentation of Malignant Peritoneal Mesothelioma: Two Case Reports

February 20, 2023 | Comments Off on Unusually Aggressive Presentation of Malignant Peritoneal Mesothelioma: Two Case Reports

Case Reports in Oncology 2022 November 8 [Link] Dominik Neff, Barbara-Christina Padberg Sgier, Hannah Dietze, Joachim Müller, Martin Früh Abstract Malignant peritoneal mesothelioma is a rare disease. Patients mainly present…

A novel pH sensitive theranostic PLGA nanoparticle for boron neutron capture therapy in mesothelioma treatment

February 17, 2023 | Comments Off on A novel pH sensitive theranostic PLGA nanoparticle for boron neutron capture therapy in mesothelioma treatment

Scientific Reports 2023 January 12 [Link] Jacopo Sforzi, Alberto Lanfranco, Rachele Stefania, Diego Alberti, Valeria Bitonto, Stefano Parisotto, Polyssena Renzi, Nicoletta Protti, Saverio Altieri, Annamaria Deagostino, Simonetta Geninatti Crich Abstract…

Carbon-ion beam irradiation in combination with cisplatin effectively suppresses xenografted malignant pleural mesothelioma

February 16, 2023 | Comments Off on Carbon-ion beam irradiation in combination with cisplatin effectively suppresses xenografted malignant pleural mesothelioma

American Journal of Cancer Research 2022 December 15 [Link] Sei Sai, Taiju Yamada, Keiko Ito, Nobuyuki Kanematsu, Masao Suzuki, Mitsuhiro Hayashi, Masashi Koto Abstract Malignant pleural mesothelioma (MPM) is a…

Well-differentiated Papillary Mesothelial Tumour of the Tunica Vaginalis Testis – A Rare Lesion, but one Pathologists Should Know About Two Patient Reports and a Review of the Literature

February 15, 2023 | Comments Off on Well-differentiated Papillary Mesothelial Tumour of the Tunica Vaginalis Testis – A Rare Lesion, but one Pathologists Should Know About Two Patient Reports and a Review of the Literature

International Journal of Surgical Pathology 2023 January 9 [Link] Johannes Kläger, Felicitas Oberndorfer, Cristophe Brunel, Julian Veser, Eva Compérat Abstract Besides malignant mesothelioma, benign mesothelial neoplasms do exist in the…

Thiolate DNAzymes on Gold Nanoparticles for Isothermal Amplification and Detection of Mesothelioma-derived Exosomal PD-L1 mRNA

February 14, 2023 | Comments Off on Thiolate DNAzymes on Gold Nanoparticles for Isothermal Amplification and Detection of Mesothelioma-derived Exosomal PD-L1 mRNA

Analytical Chemistry 2023 January 9 [Link] Sareh Zhand, Ying Zhu, Hojjatollah Nazari, Mohammad Sadraeian, Majid Ebrahimi Warkiani, Dayong Jin Abstract Catalytic DNAzymes have been used for isothermal amplification and rapid…

Serum Extracellular Vesicle-Derived microRNAs as Potential Biomarkers for Pleural Mesothelioma in a European Prospective Study

February 13, 2023 | Comments Off on Serum Extracellular Vesicle-Derived microRNAs as Potential Biomarkers for Pleural Mesothelioma in a European Prospective Study

Cancers 2022 December 25 [Link] Elisabetta Casalone, Giovanni Birolo, Barbara Pardini, Alessandra Allione, Alessia Russo, Chiara Catalano, Manlio Mencoboni, Daniela Ferrante, Corrado Magnani, Marika Sculco, Irma Dianzani, Federica Grosso, Dario…

Efficacy and safety of nivolumab with ipilimumab for recurrent malignant pleural mesothelioma after primary surgical intervention

February 10, 2023 | Comments Off on Efficacy and safety of nivolumab with ipilimumab for recurrent malignant pleural mesothelioma after primary surgical intervention

International Journal of Clinical Oncology 2023 January 7 [Link] Akifumi Nakamura, Masaki Hashimoto, Nobuyuki Kondo, Seiji Matsumoto, Ayumi Kuroda, Toshiyuki Minami, Kazuhiro Kitajima, Kozo Kuribayashi, Takashi Kijima, Seiki Hasegawa Abstract…

Tislelizumab combined with anlotinib in the second-line treatment of malignant pleural mesothelioma

February 9, 2023 | Comments Off on Tislelizumab combined with anlotinib in the second-line treatment of malignant pleural mesothelioma

Medicine 2022 December 30 [Link] Dandan Zhang, Jianping Liang, Yanhua Lv, Xikun Huang, Weihong Guo Abstract Rationale: Malignant pleural mesothelioma (MPM) is a malevolent tumor originated from pleura and often…

Categories